Targeted Therapy for Pulmonary Hypertension in Premature Infants
Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, the...
Main Authors: | Shannon N Nees, Erika B Rosenzweig, Jennifer L Cohen, Gerson A Valencia Villeda, Usha S Krishnan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/7/8/97 |
Similar Items
-
The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension
by: Galina A. Alyamovskaya, et al.
Published: (2015-02-01) -
Pulmonary Vascular Underperfusion Score in Premature Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension
by: Bibhuti B. Das, et al.
Published: (2019-07-01) -
Diagnostic Approach to Pulmonary Hypertension in Premature Neonates
by: Vasantha H.S. Kumar
Published: (2017-08-01) -
Increased risk of pulmonary hypertension following premature birth
by: Estelle Naumburg, et al.
Published: (2019-08-01) -
The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia
by: Eui Kyung Choi, et al.
Published: (2015-10-01)